NeoGenomics (NASDAQ:NEO) Releases FY 2023 Earnings Guidance
NeoGenomics (NASDAQ:NEO – Get Free Report) updated its FY 2023 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of -$0.28–$0.23 for the period, compared to the consensus estimate of -$0.36. The company issued revenue guidance of $565.00 million-$575.00 million, compared to the consensus revenue estimate of $562.42 million. NeoGenomics also updated […]